S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis.

Yuichi YamasakiSyuji TakeiHiroyuki ImanakaTomohiro KubotaYukiko NonakaTomoko TakezakiYoshifumi Kawano

Published in: Clinical rheumatology (2018)

Measuring both serum S100A12 and VEGF levels may be useful for differentiating patients with Blau syndrome and FMF from those with sJIA at the early stage.

Keyphrases

vascular endothelial growth factor
juvenile idiopathic arthritis
early stage
endothelial cells
case report
disease activity
early onset
systemic lupus erythematosus